Ellen Heitlinger: Webinar on NSCLC Mutations and Precision Oncology

Ellen Heitlinger, CEO at healthbook.org, shared a post on LinkedIn:

“Mutations in NSCLC: Bringing Precision Oncology to Life

 What to expect:

• Common EGFR Mutations in NSCLC
• Treatment Strategies for Common Mutations Beyond EGFR
• Dermatologic Side-Effects of Targeted Therapies: How to Prevent and Manage Them?

March 18, 2026 | 17:30–19:00 CET
Live virtual CME-accredited webinar

Chair:

1. Prof. Dr Dr Sacha Rothschild – Baden Cantonal Hospital

Faculty:

• Prof. Nicolas Girard – Institute Curie, Paris
• Prof. Alfredo Addeo – Geneva University Hospitals
• Prof. Reinhard Dummer – University Hospital Zurich

Participate live and engage directly with our experts.

Register for free at healthbook.org or use link.”